ALX Uranium Announces Lon Shaver Joins Advisory Board -Stock Options Granted
Vancouver, July 22nd, 2016 – ALX Uranium Corp. (“ALX” or the “Company) (TSXv: AL; FSE: 6LLN; OTCQX: ALXEF) is pleased to announce that Mr. Lon Shaver has joined the Company’s Advisory Board.
Mr. Shaver has almost 20 years of experience in the Canadian mining sector, including investment banking roles with Raymond James Ltd., Merrill Lynch Canada Inc. and Midland Walwyn Capital Inc., where he completed numerous financing and M&A mandates. His corporate experience includes CFO roles with a publicly-listed mining company and a private technology company. Mr. Shaver began his career in equity research at Gordon Capital Corporation, where he focused on mining and fertilizer companies. He has a B. Comm. degree from Concordia University and holds the CFA designation.
The Board of Directors has approved the allocation of 1,275,000 incentive stock options to officers, directors, employees, advisors and consultants of the Company. Of the shares allocated, 900,000 have been issued to directors and officers. The options are exercisable at $0.10 per share for a period of five years from issuance. The options are subject to the following vesting provisions – one third (1/3) of the options will vest immediately, one third (1/3) in one year and one third (1/3) in two years of the allocation date.
About ALX Uranium Corp.
ALX Uranium Corp. was formed as the result of a business combination between Lakeland Resources Inc. and Alpha Exploration Inc. ALX is based in Vancouver and its common shares are listed on the TSX Venture Exchange under the symbol "AL", on the Frankfurt Stock Exchange under the symbol “6LLN” and in the United States OTCQX under the symbol “ALXEF”. ALX is actively exploring a portfolio of early-stage properties. Technical reports are available on SEDAR (www.sedar.com) for several of the Company’s active properties. ALX continually and proactively reviews opportunities for new properties, whether by staking, joint venture or acquisition.
For more information, please visit the corporate website at www.alxuranium.com or contact Roger Leschuk, Corporate Communications at Ph: 604.681.1568 or TF: 1.877.377.6222 or email: firstname.lastname@example.org
On Behalf of the Board of Directors
President, CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of theTSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Aktuelle Pressemeldungen dieses Unternehmens direkt in Ihr Postfach:
Mitteilung übermittelt durch IRW-Press.com. Für den Inhalt ist der Aussender verantwortlich.
Kostenloser Abdruck mit Quellenangabe erlaubt.